Positive signals from Washington

US biotech seems reenergized, but unsettled policy questions take a back seat to pending national elections, particularly with the presidency at stake. Jeffrey L Fox reports.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Fox, J.L. Nat. Biotechnol. 29, 303–305 (2011).

  2. 2

    Anonymous. Nat. Biotechnol. 30, 198 (2012).

  3. 3

    Fox, J.L. Nat. Biotechnol. 29, 953–954 (2011).

  4. 4

    Fox, J.L. Nat. Biotechnol. 29, 1062 (2011).

  5. 5

    Mullard, A. Nat. Rev. Drug Discov. 11, 91–94 (2012).

  6. 6

    Fox, J.L. Nat. Biotechnol. 28, 1141–1142 (2010).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fox, J. Positive signals from Washington. Nat Biotechnol 30, 306–308 (2012). https://doi.org/10.1038/nbt.2175

Download citation

Further reading